An increased fraction of a putative M2-polarized phenotype, as exemplified by an increase of CD163+ (and CD206+) cells in the lymph nodes, was similarly observed in lung samples of COVID-19 patients (57, 58). The gene discussed is CD163; the disease is COVID-19.